Mersana Therapeutics
MRSN
#8105
Rank
โ‚ฌ0.18 B
Marketcap
1,53ย โ‚ฌ
Share price
-8.05%
Change (1 day)
-16.33%
Change (1 year)

Revenue for Mersana Therapeutics (MRSN)

Revenue in 2024 (TTM): โ‚ฌ31.65 Million

According to Mersana Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ33.37 Million. In 2023 the company made a revenue of โ‚ฌ33.33 Million an increase over the revenue in the year 2022 that were of โ‚ฌ24.78 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Mersana Therapeutics from 2016 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ31.65 M-5.04%
2023 โ‚ฌ33.33 M34.54%
2022 โ‚ฌ24.78 M63680.85%
2021 โ‚ฌ0.03 M-94.24%
2020 โ‚ฌ0.67 M-98.21%
2019 โ‚ฌ37.6 M306.01%
2018 โ‚ฌ9.26 M-36.66%
2017 โ‚ฌ14.62 M-38.89%
2016 โ‚ฌ23.92 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA